Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice | PLOS ONE
Establishment of combined diagnostic models of Alzheimer's disease in a Chinese cohort: the Chongqing Ageing & Dementia Study (CADS) | Translational Psychiatry
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ? | Alzheimer's Research & Therapy | Full Text
CSF markers for incipient Alzheimer's disease - ScienceDirect
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease | Biomarkers in Medicine
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study - The Lancet Neurology
Practice
Biomarkers for Alzheimer's disease: current status and prospects for the future - Blennow - 2018 - Journal of Internal Medicine - Wiley Online Library
Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? | Semantic Scholar
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression | Scientific Reports
Frontiers | Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study - The Lancet
JPM | Free Full-Text | Molecular and Imaging Biomarkers in Alzheimer's Disease: A Focus on Recent Insights | HTML
SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease | Scientific Reports
IJMS | Free Full-Text | Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria | HTML
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis | PLOS ONE
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood | HTML
![PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02efe2abec13a309916c6860de5ad8a8a096fe5d/7-Figure3-1.png "PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar")
PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
CSF markers for incipient Alzheimer's disease - The Lancet Neurology
![PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02efe2abec13a309916c6860de5ad8a8a096fe5d/4-Table2-1.png "PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar")
PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar
Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification | Scientific Reports
CSF markers for incipient Alzheimer's disease - ScienceDirect
Scatterplot of Cerebrospinal Fluid (CSF) A42:P-Tau Ratio and CSF T-Tau... | Download Scientific Diagram
